Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03242382
Title Trial of Palbociclib in Second Line of Advanced Sarcomas With CDK4 Overexpression. (PalboSarc)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Grupo Espanol de Investigacion en Sarcomas
Indications

osteosarcoma

sarcoma

Therapies

Palbociclib

Age Groups: adult | senior
Covered Countries ESP

Additional content available in CKB BOOST